table of content
1 Introduction to Research & Analysis Reports
1.1 Infectious Diseases Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Diseases Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Diseases Molecular Diagnostics Overall Market Size
2.1 Global Infectious Diseases Molecular Diagnostics Market Size: 2022 VS 2029
2.2 Global Infectious Diseases Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Diseases Molecular Diagnostics Players in Global Market
3.2 Top Global Infectious Diseases Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Diseases Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Diseases Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Infectious Diseases Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Diseases Molecular Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction PCR
4.1.3 Molecular Hybridization
4.1.4 Biochip
4.1.5 Others
4.2 By Type - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.1.4 Others
5.2 By Application - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Infectious Diseases Molecular Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Infectious Diseases Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Diseases Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Infectious Diseases Molecular Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.3.2 US Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.3 Canada Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.4.2 Germany Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.3 France Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.4 U.K. Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.5 Italy Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.6 Russia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.4.8 Benelux Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.5.2 China Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.3 Japan Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.4 South Korea Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.5.6 India Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.6.2 Brazil Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.6.3 Argentina Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, 2018-2029
6.7.2 Turkey Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.3 Israel Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
6.7.5 UAE Infectious Diseases Molecular Diagnostics Market Size, 2018-2029
7 Infectious Diseases Molecular Diagnostics Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Infectious Diseases Molecular Diagnostics Major Product Offerings
7.1.4 Roche Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Infectious Diseases Molecular Diagnostics Major Product Offerings
7.2.4 Qiagen Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Infectious Diseases Molecular Diagnostics Major Product Offerings
7.3.4 Illumina Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Infectious Diseases Molecular Diagnostics Major Product Offerings
7.4.4 Abbott Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Hologic
7.5.1 Hologic Company Summary
7.5.2 Hologic Business Overview
7.5.3 Hologic Infectious Diseases Molecular Diagnostics Major Product Offerings
7.5.4 Hologic Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Hologic Key News & Latest Developments
7.6 BioMerieux
7.6.1 BioMerieux Company Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Major Product Offerings
7.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 BioMerieux Key News & Latest Developments
7.7 Danaher (Cepheid)
7.7.1 Danaher (Cepheid) Company Summary
7.7.2 Danaher (Cepheid) Business Overview
7.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Major Product Offerings
7.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Danaher (Cepheid) Key News & Latest Developments
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Major Product Offerings
7.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Myriad Genetics Key News & Latest Developments
7.9 DAAN Gene
7.9.1 DAAN Gene Company Summary
7.9.2 DAAN Gene Business Overview
7.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Major Product Offerings
7.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DAAN Gene Key News & Latest Developments
7.10 Agilent
7.10.1 Agilent Company Summary
7.10.2 Agilent Business Overview
7.10.3 Agilent Infectious Diseases Molecular Diagnostics Major Product Offerings
7.10.4 Agilent Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Agilent Key News & Latest Developments
7.11 Genomic Health
7.11.1 Genomic Health Company Summary
7.11.2 Genomic Health Business Overview
7.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Major Product Offerings
7.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Genomic Health Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Business Overview
7.12.3 BD Infectious Diseases Molecular Diagnostics Major Product Offerings
7.12.4 BD Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.12.5 BD Key News & Latest Developments
7.13 Foundation Medicine
7.13.1 Foundation Medicine Company Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Major Product Offerings
7.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Foundation Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
